Published in Cancer Weekly, January 5th, 2010
"However, the adjuvant therapies given to prevent such recurrences also have significant side effects and associated risks," wrote A.P. Myers and colleagues.
The researchers concluded: "The ability to select patients with the highest risk of recurrence and greatest therapeutic response will improve rectal cancer care. (Clin Cancer Res 2009;15(22):6748-50)."
Myers and colleagues published their study in Clinical Cancer Research (Getting Knit-PI3Ky: PIK3CA Mutation Status to Direct Multimodality Therapy'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.